A carregar...
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
Research in cancer immunology is currently accelerating following a series of cancer immunotherapy breakthroughs during the last 5 years. Various monoclonal antibodies which block the interaction between checkpoint molecules PD-1 on immune cells and PD-L1 on cancer cells have been used to successful...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986262/ https://ncbi.nlm.nih.gov/pubmed/27532023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0153-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|